Free Trial

SI-BONE Q4 2022 Earnings Report

SI-BONE logo
$13.25 +0.20 (+1.53%)
(As of 12/20/2024 05:16 PM ET)

SI-BONE EPS Results

Actual EPS
-$0.32
Consensus EPS
-$0.42
Beat/Miss
Beat by +$0.10
One Year Ago EPS
N/A

SI-BONE Revenue Results

Actual Revenue
$31.95 million
Expected Revenue
$31.80 million
Beat/Miss
Beat by +$150.00 thousand
YoY Revenue Growth
N/A

SI-BONE Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

The #1 Coin for November 2024 (Ad)

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

SI-BONE Earnings Headlines

SI-Bone assumed with an Overweight at Morgan Stanley
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
See More SI-BONE Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SI-BONE? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SI-BONE and other key companies, straight to your email.

About SI-BONE

SI-BONE (NASDAQ:SIBN), a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

View SI-BONE Profile

More Earnings Resources from MarketBeat

Upcoming Earnings